BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17211556)

  • 21. [Changes in the protease inhibitor activity of the blood serum in patients with disseminated sclerosis].
    Chapovs'ka TI
    Lik Sprava; 1994; (9-12):118-20. PubMed ID: 7604547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease inhibitors in porcine serum and their immunological relationships to human protease inhibitors.
    Weström BR
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1861-7. PubMed ID: 93563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protease inhibitors in alpha 1-antitrypsin-deficient children.
    Sveger T
    Pediatr Res; 1985 Aug; 19(8):834-5. PubMed ID: 3875830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of smoking on peripheral blood leukocytes and serum antiproteases.
    Bridges RB; Wyatt RJ; Rehm SR
    Eur J Respir Dis Suppl; 1985; 139():24-33. PubMed ID: 2995105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin III activity and concentration in diabetes mellitus.
    Patrassi GM; Picchinenna R; Vettor R; Cappellato G; Coccarielli D; Girolami A
    Thromb Haemost; 1985 Aug; 54(2):415-7. PubMed ID: 3936213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status.
    Andrew M; Massicotte-Nolan PM; Karpatkin M
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):495-500. PubMed ID: 6193532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced 25(OH) Vitamin D Association with Lower Alpha-1-Antitrypsin Blood Levels in Type 2 Diabetic Patients.
    Lindley VM; Bhusal K; Huning L; Levine SN; Jain SK
    J Am Coll Nutr; 2021 Feb; 40(2):98-103. PubMed ID: 32275481
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
    Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations.
    Bryan CL; Beard KS; Pott GB; Rahkola J; Gardner EM; Janoff EN; Shapiro L
    Clin Invest Med; 2010 Dec; 33(6):E384-9. PubMed ID: 21134340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The protease-antiprotease system in pathogenesis of transient arthritis of a single joint in children].
    Okoński M; Gregosiewicz A; Gil L
    Chir Narzadow Ruchu Ortop Pol; 1990; 55(3):205-8. PubMed ID: 1369947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma inactive renin in patients with diabetes mellitus: effects of standing and the relation to serum protease inhibitor.
    Shimojo N; Fujii S; Funae Y; Wada M
    Endocrinol Jpn; 1983 Apr; 30(2):147-53. PubMed ID: 6196185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
    Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H
    Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypsin inhibitory capacity in vernal keratoconjunctivitis.
    Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypes and serum level of alpha-1-antitrypsin in lung cancer.
    Topic A; Ljujic M; Petrovic-Stanojevic N; Dopudja-Pantic V; Radojkovic D
    J BUON; 2011; 16(4):672-6. PubMed ID: 22331720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.
    Berg TJ; Dahl-Jørgensen K; Torjesen PA; Hanssen KF
    Diabetes Care; 1997 Jun; 20(6):1006-8. PubMed ID: 9167115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement and protease inhibitors in the mucocutaneous lymph node syndrome.
    Rieger CH; Kawasaki T; Yanase Y; Pollack U
    Eur J Pediatr; 1983 Apr; 140(2):92-7. PubMed ID: 6192994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing reference values for the measurement of alpha 1-antitrypsin in serum: comparison of three methods.
    Gaidulis L; Muensch HA; Maslow WC; Borer WZ
    Clin Chem; 1983 Oct; 29(10):1838-40. PubMed ID: 6413093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.